Pantoprazole therapy in the long-term management of severe acid peptic disease

American Journal of Gastroenterology

Volumn 96, Issue 6, 2001, Pages 1767-1776

  Bardhan, Karna Dev ^a   Cherian, Pradip ^b   Bishop, Anne E ^c   Polak, Julia M ^c   Romanska, H ^c   Perry, Michael J ^a   Rowland, Anne ^a   Thompson, Mary ^a   Morris, Pamela ^a   Schneider, Andreas ^d   Fischer, Renata ^d   Ng, W ^d   Luhmann R ^d   McCaldin, Brian ^e  

^a ROTHERHAM GENERAL HOSPITAL   (United Kingdom)

^b GRADUATE HOSPITAL   (United States)

^c HAMMERSMITH HOSPITAL   (United Kingdom)

^d ALTANA PHARMA AG   (Germany)

^e Scicom   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84878669628     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2001.03185.x     Document Type: Article

References (19)

1. Similarities and differences in the properties of substituted benzimidazoles: A comparison between pantoprazole and related compounds
2. Endoscopy of the esophagus
3. The Sydney system: A new classification of gastritis
4. The unlabelled antibody peroxidase antiperoxidase (PAP) method
5. Histopathological classification of nonantral gastric endocrine growths in man
6. Implication of a review of long-term safety of omeprazole and management strategies for peptic disease
7. Efficacy and safety of long-term treatment with omeprazole in patients with acid related diseases resistant to ranitidine
8. Gastric mucosa during treatment with lansoprazole: Helicobacter pylori is a risk factor for argyrophil cell hyperplasia
9. Reversibility of plasma changes induced by omeprazole or ranitidine in man
10. Hypergastrinaemia induced by acid blockade evokes enterochromaffin-like (ECL) cell hyperplasia in chicken, hamster and guinea-pig stomach
11. Time-dependent changes in enterochromaffin-like cell kinetics in stomach of hypergastrinemic rats
12. Review: The enterochromaffin-like cell, intragastric acidity and the trophic effect of plasma gastrin
13. Inter-relationship between serum gastrin levels, gastric mucosal histology and gastric endocrine cell growth
14. Gastrin effects on isolated rat enterochromaffin-like cells in primary culture
15. Long-term omeprazole therapy in peptic ulcer disease: Gastrin, endocrine cell growth and gastritis
16. The long-term management of H2-blocker refractory acid peptic disease with pantoprazole
17. Histology and safety parameters during long-term maintenance with pantoprazole in severe acid-peptic disease
18. Helicobacter pylori augments the pH increasing effect of omeprazole in patients with duodenal ulcer
19. Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication